132 related articles for article (PubMed ID: 20871388)
1. Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy.
Gitau RW; Graham SM; Masese LN; Overbaugh J; Chohan V; Peshu N; Richardson BA; Jaoko W; Ndinya-Achola JO; McClelland RS
AIDS; 2010 Nov; 24(17):2733-7. PubMed ID: 20871388
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.
Mcclelland RS; Wang CC; Mandaliya K; Overbaugh J; Reiner MT; Panteleeff DD; Lavreys L; Ndinya-Achola J; Bwayo JJ; Kreiss JK
AIDS; 2001 Jan; 15(1):105-10. PubMed ID: 11192850
[TBL] [Abstract][Full Text] [Related]
3. Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy.
Graham SM; Masese L; Gitau R; Richardson BA; Mandaliya K; Peshu N; Jaoko W; Ndinya-Achola J; Overbaugh J; McClelland RS
Sex Transm Infect; 2011 Mar; 87(2):114-7. PubMed ID: 20980464
[TBL] [Abstract][Full Text] [Related]
4. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.
Graham SM; Holte SE; Peshu NM; Richardson BA; Panteleeff DD; Jaoko WG; Ndinya-Achola JO; Mandaliya KN; Overbaugh JM; McClelland RS
AIDS; 2007 Feb; 21(4):501-7. PubMed ID: 17301569
[TBL] [Abstract][Full Text] [Related]
5. Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy.
Woo VG; Liegler T; Cohen CR; Sawaya GF; Smith-McCune K; Bukusi EA; Huchko MJ
AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1000-5. PubMed ID: 23594240
[TBL] [Abstract][Full Text] [Related]
6. Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study.
Huchko MJ; Woo VG; Liegler T; Leslie H; Smith-McCune K; Sawaya GF; Bukusi EA; Cohen CR
BJOG; 2013 Sep; 120(10):1233-9. PubMed ID: 23647852
[TBL] [Abstract][Full Text] [Related]
7. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
8. Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy?
Huchko MJ; Woo V; Liegler T; Leddy A; Smith-McCune K; Sawaya GF; Bukusi EA; Cohen CR
J Low Genit Tract Dis; 2013 Jul; 17(3):354-60. PubMed ID: 23486070
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.
Masese LN; Graham SM; Gitau R; Peshu N; Jaoko W; Ndinya-Achola JO; Mandaliya K; Richardson BA; Overbaugh J; McClelland RS
BMC Infect Dis; 2011 Nov; 11():307. PubMed ID: 22047086
[TBL] [Abstract][Full Text] [Related]
10. Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.
Neely MN; Benning L; Xu J; Strickler HD; Greenblatt RM; Minkoff H; Young M; Bremer J; Levine AM; Kovacs A
J Acquir Immune Defic Syndr; 2007 Jan; 44(1):38-42. PubMed ID: 17106279
[TBL] [Abstract][Full Text] [Related]
11. Effect of intrauterine device use on cervical shedding of HIV-1 DNA.
Richardson BA; Morrison CS; Sekadde-Kigondu C; Sinei SK; Overbaugh J; Panteleeff DD; Weiner DH; Kreiss JK
AIDS; 1999 Oct; 13(15):2091-7. PubMed ID: 10546862
[TBL] [Abstract][Full Text] [Related]
12. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
Cu-Uvin S; DeLong AK; Venkatesh KK; Hogan JW; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM
AIDS; 2010 Oct; 24(16):2489-97. PubMed ID: 20736815
[TBL] [Abstract][Full Text] [Related]
13. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.
Low AJ; Konate I; Nagot N; Weiss HA; Kania D; Vickerman P; Segondy M; Mabey D; Pillay D; Meda N; van de Perre P; Mayaud P;
J Acquir Immune Defic Syndr; 2014 Feb; 65(2):237-45. PubMed ID: 24226060
[TBL] [Abstract][Full Text] [Related]
14. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.
Graham SM; Jalalian-Lechak Z; Shafi J; Chohan V; Deya RW; Jaoko W; Mandaliya KN; Peshu NM; Overbaugh J; McClelland RS
J Acquir Immune Defic Syndr; 2012 Aug; 60(5):511-8. PubMed ID: 22592588
[TBL] [Abstract][Full Text] [Related]
16. Cervical shedding of human T cell lymphotropic virus type I is associated with cervicitis.
Zunt JR; Dezzutti CS; Montano SM; Thomas KK; Alarcón JO; Quijano E; Courtois BN; Sánchez JL; Campos P; Gotuzzo E; Guenthner PC; Lal RB; Holmes KK
J Infect Dis; 2002 Dec; 186(11):1669-72. PubMed ID: 12447745
[TBL] [Abstract][Full Text] [Related]
17. Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapy-adherent women.
Henning TR; Kissinger P; Lacour N; Meyaski-Schluter M; Clark R; Amedee AM
J Infect Dis; 2010 Nov; 202(10):1543-52. PubMed ID: 20925530
[TBL] [Abstract][Full Text] [Related]
18. Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women.
Mitchell C; Balkus JE; McKernan-Mullin J; Cohn SE; Luque AE; Mwachari C; Cohen CR; Coombs R; Frenkel LM; Hitti J
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):143-8. PubMed ID: 23018377
[TBL] [Abstract][Full Text] [Related]
19. Increased Cervical Human Immunodeficiency Virus (HIV) RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure Compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3.
Greene SA; McGrath CJ; Lehman DA; Marson KG; Trinh TT; Yatich N; Nyongesa-Malava E; Kiptinness C; Richardson BA; John-Stewart GC; De Vuyst H; Sakr SR; Mugo NR; Chung MH
Clin Infect Dis; 2018 May; 66(11):1778-1784. PubMed ID: 29272368
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso.
Nagot N; Ouedraogo A; Weiss HA; Konate I; Sanon A; Defer MC; Sawadogo A; Andonaba JB; Vallo R; Becquart P; Segondy M; Mayaud P; Van de Perre P;
Sex Transm Infect; 2008 Jun; 84(3):167-70. PubMed ID: 18055582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
